Primary Care Companion E-lert


The Primary Care Companion for
CNS Disorders

Register | Current Issue | Information for Authors | About E-Lerts

Improvement in Functional Outcomes With Adjunctive Aripiprazole Versus Placebo in Major Depressive Disorder: A Pooled Post Hoc Analysis of 3 Short-Term Studies

Tanya J. Fabian, PharmD, PhD; Zachary J. Cain, PharmD; Diane Ammerman, PharmD; James M. Eudicone, MS, MBA; Yan Tang, MS; Linda M. Rollin, PhD; Robert A. Forbes, PhD; Robert M. Berman, MD; and Ross A. Baker, PhD, MBA

A potential treatment option for residual depressive symptoms is to add a low-dose antipsychotic to an antidepressant regimen. In this article, Fabian and colleagues analyzed data from 3 similarly designed clinical trials that investigated the effect of combining the atypical antipsychotic aripiprazole with an antidepressant on improving a patient’s functional impairment compared with receiving antidepressants alone.

[Abstract] [Full Text]

For more free peer-reviewed articles, visit the Companion at If you are having trouble reading this E-Lert, see

Like us on Facebook
Follow us on Twitter

You are receiving this update as a benefit of your membership.

To ensure delivery of these messages add to your address book. If you would not like to receive further E-Lerts, go to and click the "Unsubscribe from E-Lerts" link. If you are having trouble unsubscribing, contact the web administrator for assistance.

If you are having trouble with your membership, contact our circulation department. Direct any other questions or comments to the web administrator.

Physicians Postgraduate Press, Inc. | 850 Ridge Lake Boulevard, Suite 300 | Memphis, TN 38120

Please do not reply directly to this e-mail. Neither nor any of its family of websites will ask you to send us profile information via e-mail.

If you cannot read this, go to

© Copyright 2012, Physicians Postgraduate Press, Inc. All rights reserved.